Application Nr Approved Date Route Status External Links
ANDA074217 1994-05-27 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Hypertension Metoprolol Tartrate Tablets, Usp Are Indicated For The Treatment Of Hypertension. They May Be Used Alone Or In Combination With Other Antihypertensive Agents. Angina Pectoris Metoprolol Tartrate Tablets, Usp Are Indicated In The Long-Term Treatment Of Angina Pectoris. Myocardial Infarction Metoprolol Tartrate Tablets, Usp Are Indicated In The Treatment Of Hemodynamically Stable Patients With Definite Or Suspected Acute Myocardial Infarction To Reduce Cardiovascular Mortality. Treatment With Intravenous Metoprolol Tartrate Can Be Initiated As Soon As The Patient’s Clinical Condition Allows (see Dosage And Administration , Contraindications , And Warnings ).

All Formulated Excipients (7 Total)

Name Structure Kind Function Status
1. Cellulose, Microcrystalline CELLULOSE, MICROCRYSTALLINE Unresolved
2. Talc TALC Unresolved DYE-Dye GRAS-Generally recognized as safe.
3. Povidones POVIDONES Unresolved
4. Magnesium Stearate MAGNESIUM STEARATE Molecular AF-Antifoaming (or defoaming) agent , MISC-Miscellaneous REG-Food additives for which a petition has been filed and a regulation issued.
5. Hypromelloses HYPROMELLOSES Unresolved
6. Titanium Dioxide TITANIUM DIOXIDE Unresolved DYE-Dye
7. Polyethylene Glycols POLYETHYLENE GLYCOLS Unresolved

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Metoprolol Tartrate METOPROLOL TARTRATE ZINC1530717

Comments